Comparison of a 22G crown-cut needle with a conventional 22G needle with EBUS guidance in diagnosis of sarcoidosis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00024714

Enrollment

Registered

2021-03-16

Start date

2020-03-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D86.0

Interventions

Group 1: Endobronchial transbronchial-needle aspiration with conventional needle (Vizishot NA-201SX-4022 from Olympus) Group 2: Endobronchial transbronchial-needle aspiration with crown-cut needle (S

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with suspected sarcoidosis 2. Ager= 18 years 3. Signed delcaration of consent

Exclusion criteria

Exclusion criteria: 1. Increased risk of bleeding a. Known predisposition of bleeding b. INR> 1.5 or Quick value <60% c. Increased Partial Thromboplastin Time (PTT) d. Platelet count <50 / nl e. Effective use of anticoagulants or Antiplatelet agents prior to examination 2. Clinically relevant medical or mental illnesses that may affect the patient's judgment and / or his participation in the study 3. Participation in the study not desired

Design outcomes

Primary

Measure	Time frame
Comparison of the two needle types with regard to the question of whether the new biopsy needle achieves a better diagnostic accuracy.	—

Secondary

Measure	Time frame
Comparison of the two needle types with regard to: - Examination duration - Complications - Weight, composition, macroscopy of the samlpe material - Quality of the sample material	—

Countries

Germany

Contacts

Public ContactKaid Darwiche

Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH

kaid.darwiche@rlk.uk-essen.de0201 433-01

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026